A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

T1 glottic laryngeal cancer: the role of routine follow-up visits in detecting local recurrence




TekijätPakkanen Pihla, Ilmarinen Taru, Halme Elina, Irjala Heikki, Koivunen Petri, Pukkila Matti, Ventelä Sami, Hagström Jaana, Aaltonen Leena-Maija

KustantajaSpringer Science and Business Media Deutschland GmbH

Julkaisuvuosi2021

JournalEuropean Archives of Oto-Rhino-Laryngology

Tietokannassa oleva lehden nimiEuropean Archives of Oto-Rhino-Laryngology

eISSN1434-4726

DOIhttps://doi.org/10.1007/s00405-021-06983-3

Verkko-osoitehttps://link.springer.com/article/10.1007%2Fs00405-021-06983-3

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/66618881


Tiivistelmä

Purpose We assessed the treatment outcome and the benefts of routine follow-up visits in T1 glottic laryngeal squamous
cell carcinoma (LSCC).
Methods: Medical records of patients diagnosed with stage T1 glottic LSCC (N=303) in fve Finnish university hospitals between 2003 and 2015 were reviewed. Moreover, data from the Finnish Cancer Registry and the Population Register Center were collected.
Results: Of all 38 recurrences, 26 (68%) were detected during a routine follow-up visit, and over half (21 of 38, 55%) presented without new symptoms. Primary treatment method (surgery vs. radiotherapy) was not connected with 5-year diseasespecifc survival (DSS) or laryngeal preservation rate.
Conclusion: The majority of recurrences were detected on a routine follow-up visit, and local recurrences often presented without new symptoms. Routine post-treatment follow-up of T1 glottic LSCC seems benefcial.
Trial registration Trial registration number and date of registration HUS/356/2017 11.12.2017.


Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 15:21